Analysed CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) News Sources
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
30-09-2026
biopharmadive.com
Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential
22-05-2026
marketbeat.com
Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?
25-05-2026
yahoo.com
Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference
01-06-2026
yahoo.com
Are You Looking for a Top Momentum Pick? Why Contineum Therapeutics, Inc. (CTNM) is a Great Choice
09-07-2026
yahoo.com
Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones
30-07-2026
yahoo.com
Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
25-08-2026
yahoo.com
What is the current price of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The current price of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is $13.38.
CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) absolute price change since previous trading day?
The absolute price change of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) since the previous trading day is $0.2.
CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) percentage price change since previous trading day?
The percentage price change of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) since the previous trading day is 1.5175%.
What is the most recent average sentiment score for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The most recent average sentiment score for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The most recent sentiment for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is .
SEC-8K** Filing Available For CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.